-
EP3142718
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3142718
| EP3142718 - PHASE-SHIFTING FORMULATIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.05.2021 Database last updated on 13.11.2024 | |
| Former | Examination is in progress Status updated on 03.12.2019 | ||
| Former | Request for examination was made Status updated on 17.02.2017 | ||
| Former | The international publication has been made Status updated on 16.12.2016 | Most recent event Tooltip | 21.05.2021 | Application deemed to be withdrawn | published on 23.06.2021 [2021/25] | Applicant(s) | For all designated states Ultrast, Inc. 107 Balsam Street Oceanside, New York 11572 / US | For all designated states Ultrast, Inc. Wickhams Cay P.O. Box 662 Road Town Tortola / VG | [2017/12] | Inventor(s) | 01 /
LEVINE, Howard L. 107 Balsam Street Oceanside, New York 11572 / US | 02 /
DE ZIEGLER, Dominique 2 Allée le Gramat 75015 Paris / FR | [2017/12] | Representative(s) | Michalski Hüttermann & Partner Patentanwälte mbB Kaistraße 16A 40221 Düsseldorf / DE | [N/P] |
| Former [2017/12] | Michalski Hüttermann & Partner Patentanwälte mbB Speditionstraße 21 40221 Düsseldorf / DE | Application number, filing date | 15792456.4 | 15.05.2015 | [2017/12] | WO2015US31012 | Priority number, date | US201461994491P | 16.05.2014 Original published format: US 201461994491 P | [2017/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015175899 | Date: | 19.11.2015 | Language: | EN | [2015/46] | Type: | A1 Application with search report | No.: | EP3142718 | Date: | 22.03.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.11.2015 takes the place of the publication of the European patent application. | [2017/12] | Search report(s) | International search report - published on: | KR | 19.11.2015 | (Supplementary) European search report - dispatched on: | EP | 27.10.2017 | Classification | IPC: | A61L33/00 | [2017/12] | CPC: |
A61L26/008 (EP,US);
A61L26/0023 (EP,US);
A61L26/0061 (EP,US);
A61L26/0066 (EP,US);
A61L2300/404 (EP,US);
A61L2300/41 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/12] | Title | German: | PHASENVERSCHIEBUNGSFORMULIERUNGEN | [2017/12] | English: | PHASE-SHIFTING FORMULATIONS | [2017/12] | French: | FORMULATIONS À CHANGEMENT DE PHASE | [2017/12] | Entry into regional phase | 15.12.2016 | National basic fee paid | 15.12.2016 | Search fee paid | 15.12.2016 | Designation fee(s) paid | 15.12.2016 | Examination fee paid | Examination procedure | 15.12.2016 | Examination requested [2017/12] | 15.12.2016 | Date on which the examining division has become responsible | 24.05.2018 | Amendment by applicant (claims and/or description) | 06.12.2019 | Despatch of a communication from the examining division (Time limit: M04) | 15.04.2020 | Reply to a communication from the examining division | 15.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 26.01.2021 | Application deemed to be withdrawn, date of legal effect [2021/25] | 16.02.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/25] | Fees paid | Renewal fee | 29.05.2017 | Renewal fee patent year 03 | 29.05.2018 | Renewal fee patent year 04 | 29.05.2019 | Renewal fee patent year 05 | 31.03.2020 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2002164365 (SHALABY SHALABY W [US], et al) [X] 1-5 * paragraph [0015]; claim 1 * [I] 1-15; | [X]WO8600912 (PHARMACIA AB [SE]) [X] 1,2,5 * page 1; claim - *; | [XI]US4291025 (PELLICO MICHAEL A) [X] 1,2,5,14,15 * claims 8,11 * [I] 3,4; | [XI]EP0551626 (LEK TOVARNA FARMACEVTSKIH [YU]) [X] 1-4 * page 8, line 21 - line 24; claim - * [I] 5,14,15 | International search | [XY]WO9932151 (ALLIANCE PHARMA [US], et al) [X] 5, 6 * See abstract; page 3, line 26 - page 36, line 29; claims 1, 10, 30, 31, 35-37. * [Y] 1-4; | [Y]US7727155 (DE ZIEGLER DOMINIQUE [CH]) [Y] 1-4 * See abstract; column 7, line 17 - column 16, line 44; claims 1-12. *; | [A]US6730775 (RODGERS KATHLEEN E [US], et al) [A] 1-6 * See abstract; claim 1. *; | [A]WO2013090833 (TARIX PHARMACEUTICALS LTD [US]) [A] 1-6 * See the whole document. *; | [A]WO9400134 (HOWMEDICA [US]) [A] 1-6 * See the whole document. * |